Clinical Trial Update: 64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating 64Cu-LNTH-1363S in patients with metastatic sarcoma and GI tract cancers (esophageal, gastric, pancreatic, and colorectal)…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Esophageal Cancer
• Gastric Cancer
• Pancreatic Cancer
• Sarcoma

Drugs mentioned

• 64Cu-LNTH-1363S

Snippet

Sponsor: Lantheus Medical Imaging | Conditions: Metastatic Sarcoma, Esophageal Cancer | Phase 1, Phase 2 | Status: RECRUITING